Risk factors for Cryptococcus gattii infection, British Columbia, Canada.
about
Cryptococcus gattii infectionsCurrent trends in the prevalence of Cryptococcus gattii in the United States and CanadaCryptococcus pneumonia presenting in an immunocompetent host with pulmonary asbestosis: a case reportCryptococcus gattii: an emerging fungal pathogen infecting humans and animals.Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplantRetrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997-2011.Cryptococcus strains with different pathogenic potentials have diverse protein secretomesLong-term management of asthma in First Nations and Inuit children: A knowledge translation tool based on Canadian paediatric asthma guidelines, intended for use by front-line health care professionals working in isolated communities.Autochthonous and dormant Cryptococcus gattii infections in EuropeCryptococcus gattii as an important fungal pathogen of western North America.Infection Risk and Safety of Corticosteroid Use.Cryptococcal infections in non-HIV-infected patientsIs Cryptococcus gattii a Primary Pathogen?Cryptococcus gattii: where do we go from here?Emerging invasive fungal diseases in transplantation.Cryptococcosis as an emerging systemic mycosis in dogs.Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.Cryptococcus gattii infections: contemporary aspects of epidemiology, clinical manifestations and management of infection.Fungal central nervous system infections: prevalence and diagnosis.Beyond tumor necrosis factor inhibition: the expanding pipeline of biologic therapies for inflammatory diseases and their associated infectious sequelae.What makes Cryptococcus gattii a pathogen?Immunoproteomics and immunoinformatics analysis of Cryptococcus gattii: novel candidate antigens for diagnosis.Ecological structuring of yeasts associated with trees around Hamilton, Ontario, Canada.Cryptococcus gattii in urban trees from cities in North-eastern Argentina.Central nervous system infection due to Cryptococcus gattii sensu lato in India: Analysis of clinical features, molecular profile and antifungal susceptibility.Cryptococcal infections in solid organ transplant recipients over a 15-year period at a state transplant center.Pulmonary Fungal Diseases in Immunocompetent Hosts: A Single-Center Retrospective Analysis of 35 Subjects.Cryptococcosis in non-HIV/non-transplant patients: A Brazilian case series.Cryptococcus gattii-Induced Infections in Dogs from Southern Brazil.A case report of cryptococcal meningoencephalitis presenting as uveitis.The Outbreak of Cryptococcus gattii in Western North America: Epidemiology and Clinical Issues.Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities.Influenza A Virus as a Predisposing Factor for Cryptococcosis.Cryptococcosis in solid organ transplantation.Cryptococcosis, lymphoproliferative disorders and modern day chemotherapy regimens.Cryptococcosis today: It is not all about HIV infection.Induction of Broad-Spectrum Protective Immunity against Disparate Cryptococcus Serotypes.Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death.Activity of 3'-hydroxychalcone against Cryptococcus gattii and toxicity, and efficacy in alternative animal models.Primary cutaneous cryptococcosis in Brazil: report of 11 cases in immunocompetent and immunosuppressed patients.
P2860
Q27002687-67355D5A-0A41-4D52-B896-2B243F035C88Q28080670-CBED9A47-6814-4A9B-9F43-239458C22385Q28387543-31684499-7594-402D-B959-E745D781AC49Q30403990-752DA3A3-3C29-40A2-84FB-5B00D31BDE74Q34399223-A8159B6A-E2E7-47CA-8DF9-A7D1DD13B2B0Q34549620-9811EFE3-DD27-4BCB-B4B5-AAD4DE029419Q35675255-923BBD01-A7E6-41F8-AA5D-9F9E42692208Q36251862-4CA051F2-B58A-4EE3-AD09-651F41F182C0Q36318438-2C62F38C-22CC-4B78-86E1-A6BD95A0C9CBQ36404905-2B390553-75B3-40F2-AD44-EF0F10ED9911Q36574609-D875D9B7-932F-4DFA-B1AC-6686C6020A95Q37026055-31CA4F1D-3AA0-4C2F-A018-0139ACB9B803Q37375089-D14E746E-914F-4235-B211-A8118B9D7E58Q37937029-49462732-0A06-46D2-834F-96B10D1C697FQ38052084-BABDB6D6-7B2F-4638-A336-58DCCBC5D8A3Q38131855-0042073A-F5EA-4DAD-BB6C-9EEA34B29FE5Q38154164-8D46F132-6B83-43E4-A419-79A6973FEA75Q38165199-962DBC8F-92DC-4AD8-A429-B41E34B71C14Q38176043-30D1A11D-BBD7-493D-9A5F-E9021C0B7E47Q38192553-54A95456-092F-4AA2-BE6D-3B87D036F8E5Q38650835-114FFCBB-BEF9-4AC4-9575-ADF94A643514Q39444326-8EE01EA5-4F51-413F-B6CA-249A97C972ACQ40004501-2A1D2A80-1D62-4438-B2A7-51506FB03F4EQ40108856-C0F4A0A4-031E-48D3-A7A5-BAAA0D399DFDQ40111169-DD2DE199-0829-477D-A644-E92A8962E8D9Q40440693-C02E1C0B-108E-46AC-BE4D-432017A270C4Q40675467-EEE94112-9570-417A-9AF6-0E9A18CF8D60Q40697279-3E5E1653-9A7A-47D2-AF75-94C8AB58EE9DQ40888340-C3DCADF3-3E7C-43B4-9EC4-76F769EA3DA8Q41456755-017AFF92-0076-4AC8-9B48-816C740A7003Q41493378-3506E059-9E8C-4D2C-BFCB-6F19D6F2222BQ41858553-08269994-779A-4DDF-8A0B-EB7028AE1CE0Q41919510-3AF615C9-DC38-4203-97A8-874877246AE0Q42272288-10CF836C-D94D-4C83-9C79-160286E11A26Q44793720-A6F78109-A674-42B6-AF71-3A8C94356BE4Q46262999-6DBBA2D5-A791-4918-87EE-DED21E1516DFQ47118458-C13A13F5-26C6-4766-820B-A5335F4167DEQ47660745-EBF40781-B3D7-494D-8310-0B75EE7227F3Q47963266-5E6494B0-0BF0-4E34-8864-8BB296FC3E36Q50245248-E3464307-98A1-4C94-BEB2-1BFE289EB543
P2860
Risk factors for Cryptococcus gattii infection, British Columbia, Canada.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Risk factors for Cryptococcus gattii infection, British Columbia, Canada.
@ast
Risk factors for Cryptococcus gattii infection, British Columbia, Canada.
@en
type
label
Risk factors for Cryptococcus gattii infection, British Columbia, Canada.
@ast
Risk factors for Cryptococcus gattii infection, British Columbia, Canada.
@en
prefLabel
Risk factors for Cryptococcus gattii infection, British Columbia, Canada.
@ast
Risk factors for Cryptococcus gattii infection, British Columbia, Canada.
@en
P2093
P2860
P356
P1476
Risk factors for Cryptococcus gattii infection, British Columbia, Canada.
@en
P2093
Eleni Galanis
Laura MacDougall
Marc Romney
Mike Starr
Murray Fyfe
P2860
P304
P356
10.3201/EID1702.101020
P577
2011-02-01T00:00:00Z